NFKB1 and neoplasm: In the tumor cells, aberrant activation of TLR might occur, thus increasing NF-κB activity, which upregulates pro-apoptotic genes and inhibits JNK-mediated pro-apoptotic signals, therefore favoring tumor survival [24].